$40.35 +0.18 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - New York Stock Exchange, Inc.

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Be a Buffett Dividend Investor

    Dividend.com | Jan. 18, 2017 | 08:00AM EST
  2. Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad

    Investors Business Daily | Jan. 17, 2017 | 15:52PM EST
  3. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  4. Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink

    Investors Business Daily | Jan. 13, 2017 | 13:49PM EST
  5. Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?

    Investors Business Daily | Jan. 6, 2017 | 14:56PM EST
  6. Regeneron, Sanofi Hammered After Judge Bans Amgen-Rivaling LDL-Buster

    Investors Business Daily | Jan. 6, 2017 | 12:45PM EST
  7. Stock Futures Ease, Dollar Climbs; Early Risers: Amgen, Ionis, Verizon

    Investors Business Daily | Jan. 6, 2017 | 08:05AM EST
  8. US Futures Flat Ahead Of December Payrolls; Dollar Rebounds

    TalkMarkets | Jan. 6, 2017 | 06:54AM EST
  9. After Hours: Gap Gaps Up, Amgen Blocks Rival, Shake Shack Shakeup

    Investors Business Daily | Jan. 5, 2017 | 17:16PM EST
  10. Regeneron, Sanofi LDL-Buster At Risk After Judge Upholds Amgen Patents

    Investors Business Daily | Jan. 4, 2017 | 11:26AM EST
  11. Johnson In 'Exclusive' Talks To Acquire Actelion After Sanofi Fray

    Investors Business Daily | Dec. 21, 2016 | 13:30PM EST
  12. Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High

    Investors Business Daily | Dec. 20, 2016 | 15:28PM EST
  13. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  14. Sanofi Seen In Talks With Actelion After J&J Bows Out

    Investors Business Daily | Dec. 13, 2016 | 23:54PM EST
  15. Regeneron Could Add $604 Million To 2018 Top Line On Eczema: RBC

    Investors Business Daily | Dec. 13, 2016 | 16:17PM EST
  16. Regeneron Spikes On Blurry-Eye Win Vs. Failed Ophthotech Drug

    Investors Business Daily | Dec. 12, 2016 | 13:34PM EST
  17. Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi

    TalkMarkets | Dec. 10, 2016 | 12:44PM EST
  18. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily | Dec. 8, 2016 | 15:39PM EST
  19. Sanofi May Battle Johnson & Johnson For European Biotech Actelion

    Investors Business Daily | Dec. 6, 2016 | 12:01PM EST
  20. Stocks Futures Edge Higher; Cook: Apple Watch Doing Just Fine

    Investors Business Daily | Dec. 6, 2016 | 07:54AM EST
  21. Warren Buffett’s Only 3 Dividend Stocks with 4%+ Yields

    TalkMarkets | Nov. 28, 2016 | 16:45PM EST
  22. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  23. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  24. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets | Nov. 14, 2016 | 13:21PM EST
  25. Sanofi (SNY) Beats Earnings, Revenues Rise Y/Y; Ups View

    TalkMarkets | Oct. 31, 2016 | 12:05PM EST
  26. Regeneron trading down on Sanofi news, says Piper Jaffray

    TalkMarkets | Oct. 28, 2016 | 13:28PM EST
  27. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets | Oct. 9, 2016 | 01:27AM EST
  28. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  29. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  30. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  31. Regeneron Stock Dips As Earnings Beat And Revenue Lags

    Investors Business Daily | Aug. 4, 2016 | 09:44AM EST
  32. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 11:20AM EST
  33. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 09:46AM EST
  34. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  35. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  36. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  37. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  38. Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology

    Benzinga | Jan. 11, 2016 | 05:25AM EST
  39. Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

    Benzinga | Jan. 11, 2016 | 04:20AM EST
  40. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  41. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  42. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  43. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  44. MannKind Is Plummeting

    Benzinga | Jan. 5, 2016 | 09:19AM EST
  45. Why MannKind Could Be a Value Trap

    GuruFocus | Jan. 4, 2016 | 14:15PM EST
  46. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  47. Sanofi Announces Dengvaxia Dengue Vaccine Approved in Brazil

    Benzinga | Dec. 28, 2015 | 05:33AM EST
  48. Francis Chou's Holdings Trading at Low PE

    GuruFocus | Dec. 23, 2015 | 18:10PM EST
  49. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  50. Microsoft, Intel and National Oilwell Varco Have High Dividend Yields in Bill Nygren's Portfolio

    GuruFocus | Dec. 17, 2015 | 11:54AM EST
Trading Center